There is a Medical Cannabis Gap in current Medical Malpractice policies due to FDA and Schedule 1 Restrictions. The Cannabis industry has changed a lot in the last decade with regard to potency and vehicle for use. Adult recreational use has increased by more than 25% while, Medical Education has not kept up. Pro Mal Insurance is leading on both counts, by partnering with Medical Associations and Medical Educators to offer education content created by health care professionals on Cannabis and other Schedule 1 non-FDA Approved, treatment options. Pro Mal Insurance and its supplemental policy covers the gap in your current policy and allows Providers and their patients to have honest conversations about new therapeutic options.